Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 2 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoproliferative Disorders 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Dendritic Cell Sarcoma, Interdigitating 1 Burkitt Lymphoma 1

Interventions

Radiotherapy 39 pembrolizumab 37 Carboplatin 37 Cisplatin 34 Paclitaxel 26 Pemetrexed 24 Docetaxel 18 Nivolumab 17 Magnetic Resonance Spectroscopy 17 Gemcitabine 17 Bevacizumab 17 Specimen Handling 16 Cyclophosphamide 15 osimertinib 14 Radiation 13 Irinotecan 13 Etoposide 13 Erlotinib Hydrochloride 12 durvalumab 11 Topotecan 10 Cetuximab 10 Radiosurgery 9 Immunoglobulin G 8 Fluorouracil 8 Everolimus 8 Disulfides 8 Celecoxib 8 fludarabine 7 Taxes 7 Ipilimumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lung Neoplasms × beta-Glucans × Clear all

NCT01829373 2013-04-11

Lung Cancer Vaccine Plus Oral Dietary Supplement

University of Kentucky

Phase 1 Completed

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡